Author:
Reddy Shivani P.,Lin Elaine J.,Shah Vidhi V.,Wu Jashin J.
Reference47 articles.
1. A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis;den Broeder;J Rheumatol,2002
2. Biologic therapy in erythrodermic and pustular psoriasis;Levin;J Drugs Dermatol,2014
3. Safety Information—Humira (adalimumab) injection. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm194134.htm. Accessed October 12, 2015.
4. Efficacy and safety of etanercept and adalimumab with and without a loading dose for psoriasis: a systematic review;Gilbert;J Am Acad Dermatol,2015
5. Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial;Kivitz;Clin Ther,2006
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献